Botanical Be Artri King Recall: Undeclared Diclofenac Hazard
Botanical Be recalls Artri King tablets due to undeclared diclofenac. Check lot 35421, exp 12/19/2025 for this Class I drug recall.
Stop using this now
Marketed Without an Approved NDA/ANDA: products found to contain undeclared diclofenac.
Contact the company
What happened, in plain English
Botanical Be is recalling Artri King Reforzado con Origa y Omega 3 tablets because they are marketed without an approved New Drug Application or Abbreviated New Drug Application and contain undeclared diclofenac. The affected product is packaged in 100-count bottles with UPC 7 501031 111138, specifically lot 35421 expiring on 12/19/2025. This recall covers 235 bottles distributed nationwide in the USA. Read more at govinfonow.com/recall/33037-botanical-be-artri-king-recall-undeclared-diclofenac-hazard.
Source Summary by GovInfoNow · govinfonow.com/recall/33037-botanical-be-artri-king-recall-undeclared-diclofenac-hazard · Updated October 9, 2026 · FDA enforcement record: FDA #D-0224-2024
Cite this page
“Botanical Be Artri King Recall: Undeclared Diclofenac Hazard.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/33037-botanical-be-artri-king-recall-undeclared-diclofenac-hazard. Based on FDA recall #D-0224-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0224-2024%22&limit=1).
Why it’s dangerous
The product contains undeclared diclofenac, a prescription NSAID, which was not listed on the label. This poses a risk of serious injury or allergic reaction for consumers who may be unaware they are taking a potent pharmaceutical drug while using it as a dietary supplement.
Who’s affected
Consumers in the USA who purchased Artri King Reforzado con Origa y Omega 3 tablets, particularly those with lot number 35421 and expiration date 12/19/2025. Individuals sensitive to diclofenac or NSAIDs are at risk of unexpected adverse reactions.
How to tell if you have this one
Check your bottle for the brand 'Artri King Reforzado con Origa y Omega 3', manufactured by Plantas medicinales de Mexico. Look specifically for UPC 7 501031 111138 and lot number 35421 with an expiration date of 12/19/2025.
- Brand
Botanical Be- Product
Artri King Reforzado con Origa y Omega 3 tablets, packaged in 100-count bottles, Manufactured by: Plantas medicinales- Category
Drug
All 3 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class I- Status
Ongoing- Distribution
USA Nationwide
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-0224-2024 | Artri King Reforzado con Origa y Omega 3 tablets, packaged in 100-count bottles, Manufactured by: Plantas medicinales de Mexico, Melchol Ocampo # 65 Local D, Delegacion Xochimilco CP 16800, Mexico DF, UPC 7 501031 111138; Lot 35421, exp 12/19/2025 | 235 bottles |
| D-0225-2024 | Reumo Flex caplets, packaged in 30-count boxes, Manufactured by: Grupo Yepenza de Mexico, SA de CV, Comerciantes 5824 Col Arcos de Guadalupe, Zapopan Jal Mexico, UPC 7 502214 014598; All lots, exp 10/20/2024 | — |
| D-0226-2024 | Kuka Flex Forte caplets, packaged in 30-count bottles, Manufactured by: Kukamonga, Gonzalez Ortega No 170 Col Centro, 44100 Guadalajara Jal, UPC 0736640810265; All lots, exp 12/12/2024 | 300 bottles |
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 47 days after the firm started it.
- Firm started the recall
- Published in FDA’s Enforcement Report
- FDA classified it Class I
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0224-2024 (October 20, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0224-2024 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.